| 000 | 01479 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514225013.0 | ||
| 264 | 0 | _c20050609 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJäger, M | |
| 245 | 0 | 0 |
_aOsteogenic progenitor cell potency after high-dose chemotherapy (COSS-96). _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a947-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow Cells _xcytology |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCartilage _xcytology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aChondroblastoma _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
| 650 | 0 | 4 |
_aMesenchymal Stem Cells _xcytology |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aPeriosteum _xcytology |
| 700 | 1 | _aSchultheis, A | |
| 700 | 1 | _aWesthoff, B | |
| 700 | 1 | _aKrauspe, R | |
| 773 | 0 |
_tAnticancer research _gvol. 25 _gno. 2A _gp. 947-54 |
|
| 999 |
_c15535075 _d15535075 |
||